These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23342632)

  • 41. Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.
    Voziyan PA; Hudson BG
    Cell Mol Life Sci; 2005 Aug; 62(15):1671-81. PubMed ID: 15905958
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peroxyl radicals are essential reagents in the oxidation steps of the Maillard reaction leading to generation of advanced glycation end products.
    Spiteller G
    Ann N Y Acad Sci; 2008 Apr; 1126():128-33. PubMed ID: 18448806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physicochemical analysis of structural alteration and advanced glycation end products generation during glycation of H2A histone by 3-deoxyglucosone.
    Ashraf JM; Ahmad S; Rabbani G; Jan AT; Lee EJ; Khan RH; Choi I
    IUBMB Life; 2014 Oct; 66(10):686-93. PubMed ID: 25380060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification.
    Schalkwijk CG; Stehouwer CD; van Hinsbergh VW
    Diabetes Metab Res Rev; 2004; 20(5):369-82. PubMed ID: 15343583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidation scrutiny in persuaded aging and chronological aging at systemic redox homeostasis level.
    Cebe T; Atukeren P; Yanar K; Kuruç AI; Ozan T; Kunbaz A; Sitar ME; Mirmaroufizibandeh R; Aydın S; Çakatay U
    Exp Gerontol; 2014 Sep; 57():132-40. PubMed ID: 24879971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GC-MS Method for the Quantitation of Carbohydrate Intermediates in Glycation Systems.
    Milkovska-Stamenova S; Schmidt R; Frolov A; Birkemeyer C
    J Agric Food Chem; 2015 Jul; 63(25):5911-9. PubMed ID: 26043919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Carbonyl stress-related schizophrenia--perspective on future therapy and hypotheses regarding pathophysiology of schizophrenia].
    Arai M; Miyashita M; Ichikawa T; Itokawa M
    Seishin Shinkeigaku Zasshi; 2012; 114(3):199-208. PubMed ID: 22568054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation.
    Vistoli G; De Maddis D; Cipak A; Zarkovic N; Carini M; Aldini G
    Free Radic Res; 2013 Aug; 47 Suppl 1():3-27. PubMed ID: 23767955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Advances in the Maillard reaction and glycation researches--mainly on the Namiki pathway].
    Namiki M
    Seikagaku; 2003 Jan; 75(1):37-42. PubMed ID: 12645131
    [No Abstract]   [Full Text] [Related]  

  • 50. Mitigating effects of antioxidant properties of Artemisia campestris leaf extract on hyperlipidemia, advanced glycation end products and oxidative stress in alloxan-induced diabetic rats.
    Sefi M; Fetoui H; Makni M; Zeghal N
    Food Chem Toxicol; 2010 Jul; 48(7):1986-93. PubMed ID: 20457207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transketolase A from E. coli Significantly Suppresses Protein Glycation by Glycolaldehyde and Glyoxal in Vitro.
    Klaus A; Pfirrmann T; Glomb MA
    J Agric Food Chem; 2017 Sep; 65(37):8196-8202. PubMed ID: 28880548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formation of the molten globule-like state during prolonged glycation of human serum albumin.
    Sattarahmady N; Moosavi-Movahedi AA; Ahmad F; Hakimelahi GH; Habibi-Rezaei M; Saboury AA; Sheibani N
    Biochim Biophys Acta; 2007 Jun; 1770(6):933-42. PubMed ID: 17368729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of nonenzymatic glycation and oxidative stress on the development of complicated diabetic cataracts].
    Sisková A; Wilhelm J
    Cesk Fysiol; 2000 Feb; 49(1):16-21. PubMed ID: 10953502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advanced glycation end-products prepared in solution under high pressure contain epitopes distinct from those formed in the dry reaction at high temperature.
    Staniszewska M; Jarosz J; Jon M; Gamian A
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):71-8. PubMed ID: 15761378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can Dietary Polyphenols Prevent the Formation of Toxic Compounds from Maillard Reaction?
    Del Turco S; Basta G
    Curr Drug Metab; 2016; 17(6):598-607. PubMed ID: 26953241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Maillard reaction and its consequences for a living body.
    Sztanke K; Pasternak K
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):159-62. PubMed ID: 15323185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein glycation in vivo: functional and structural effects on yeast enolase.
    Gomes RA; Oliveira LM; Silva M; Ascenso C; Quintas A; Costa G; Coelho AV; Sousa Silva M; Ferreira AE; Ponces Freire A; Cordeiro C
    Biochem J; 2008 Dec; 416(3):317-26. PubMed ID: 18651835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fructose and glucose differentially affect aging and carbonyl/oxidative stress parameters in Saccharomyces cerevisiae cells.
    Semchyshyn HM; Lozinska LM; Miedzobrodzki J; Lushchak VI
    Carbohydr Res; 2011 May; 346(7):933-8. PubMed ID: 21459368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preferential recognition of epitopes on AGE-IgG by the autoantibodies in rheumatoid arthritis patients.
    Ahmad S; Habib S; Moinuddin ; Ali A
    Hum Immunol; 2013 Jan; 74(1):23-7. PubMed ID: 23073292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural compounds containing a catechol group enhance the formation of Nε-(carboxymethyl)lysine of the Maillard reaction.
    Fujiwara Y; Kiyota N; Tsurushima K; Yoshitomi M; Mera K; Sakashita N; Takeya M; Ikeda T; Araki T; Nohara T; Nagai R
    Free Radic Biol Med; 2011 Apr; 50(7):883-91. PubMed ID: 21195168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.